ICUI logo

ICU Medical, Inc. Stock Price

NasdaqGS:ICUI Community·US$2.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

ICUI Share Price Performance

US$118.46
-62.48 (-34.53%)
32.9% undervalued intrinsic discount
US$176.50
Fair Value
US$118.46
-62.48 (-34.53%)
32.9% undervalued intrinsic discount
US$176.50
Fair Value
Price US$118.46
AnalystConsensusTarget US$176.50

ICUI Community Narratives

AnalystConsensusTarget·
Fair Value US$176.5 32.9% undervalued intrinsic discount

Infusion Therapies And Advanced Systems Will Shape Healthcare Outcomes

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
US$176.5
32.9% undervalued intrinsic discount
Revenue growth
-0.13% p.a.
Profit Margin
4.49%
Future PE
53.12x
Share price in 2028
US$222.58

Snowflake Analysis

Undervalued with moderate growth potential.

1 Risk
3 Rewards

ICU Medical, Inc. Key Details

US$2.4b

Revenue

US$1.5b

Cost of Revenue

US$850.3m

Gross Profit

US$887.2m

Other Expenses

-US$36.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.50
35.84%
-1.56%
63.2%
View Full Analysis

About ICUI

Founded
1984
Employees
15000
CEO
Vivek Jain
WebsiteView website
www.icumed.com

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Recent ICUI News & Updates

ICU Medical, Inc. (NASDAQ:ICUI) Shares Could Be 46% Below Their Intrinsic Value Estimate

Aug 25
ICU Medical, Inc. (NASDAQ:ICUI) Shares Could Be 46% Below Their Intrinsic Value Estimate

Recent updates

No updates